References
Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (1998) Prevention of chemotherapy and radiotherapy-induced emesis: results of Perugia Consensus Conference. Ann Oncol 9:811–19
Gralla RJ, Osoba D, Kris MG, Kirkbride P, Hesketh PJ, Chinnery LW, Clark-Snow R, Gill DP, Groshen S, Grunberg S, Koeller JM, Morrow GR, Perez EA, Silber JH, Pfister DG (1999) Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. J Clin Oncol 17:2971–2994
Acknowledgment statement
The Consensus Conference on Antiemetic Therapy held in Perugia, Italy, 29–31 March 2004, was given generous support by the nine oncology associations involved. In addition, unrestricted educational grants for the support of this meeting were given to the Antiemetic Study Group of the Multinational Association of Supportive Care in Cancer (MASCC) by Aventis Pharmaceuticals, GlaxoSmithKline, Helsinn Healthcare SA, Merck & Co. Inc., MGI Pharma, Inc., and Roche Laboratories Inc. The opinions expressed in these manuscripts are those of the authors and do not necessarily reflect the opinions or recommendations of the publisher or the companies and organizations that provided grants towards this process.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gralla, R.J., Roila, F. & Tonato, M. The 2004 Perugia Antiemetic Consensus Guideline process: methods, procedures, and participants. Support Care Cancer 13, 77–79 (2005). https://doi.org/10.1007/s00520-004-0756-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-004-0756-5